These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1088 related articles for article (PubMed ID: 33503010)

  • 21. Stability and compatibility of tirofiban hydrochloride during simulated Y-site administration with other drugs.
    Bergquist PA; Manas D; Hunke WA; Reed RA
    Am J Health Syst Pharm; 2001 Jul; 58(13):1218-23. PubMed ID: 11449879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of cefpirome sulfate in the presence of commonly used intensive care drugs during simulated Y-site injection.
    Allen LV; Stiles ML; Prince SJ; Sylvestri MF
    Am J Health Syst Pharm; 1995 Nov; 52(21):2427-33. PubMed ID: 8564608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Feb; 51(4):495-9. PubMed ID: 8017415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compatibility of esmolol hydrochloride with morphine sulfate and fentanyl citrate during simulated Y-site administration.
    Karnatz NN; Wong J; Kesler H; Baaske DM; Speicher ER
    Am J Hosp Pharm; 1988 Feb; 45(2):368-71. PubMed ID: 2896460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visual compatibility of defibrotide with selected drugs during simulated Y-site administration.
    Correard F; Savry A; Gauthier-Villano L; Pisano P; Pourroy B
    Am J Health Syst Pharm; 2014 Aug; 71(15):1288-91. PubMed ID: 25027536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compatibility of warfarin sodium with selected drugs and large-volume parenteral solutions.
    Martinez JF; Trissel LA; Gilbert DL
    Int J Pharm Compd; 1997; 1(5):356-8. PubMed ID: 23989380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compatibility of aminophylline and verapamil in intravenous admixtures.
    Johnson CE; Lloyd CW; Mesaros JL; Rubley GJ
    Am J Hosp Pharm; 1989 Jan; 46(1):97-100. PubMed ID: 2712035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compatibility of gemcitabine hydrochloride with 107 selected drugs during simulated Y-site injection.
    Trissel LA; Martinez JF; Gilbert DL
    J Am Pharm Assoc (Wash); 1999; 39(4):514-8. PubMed ID: 10467816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stability of flumazenil with selected drugs in 5% dextrose injection.
    Olsen KM; Gurley BJ; Davis GA; Christensen R; Monaghan MS
    Am J Hosp Pharm; 1993 Sep; 50(9):1907-12. PubMed ID: 8135238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
    Trissel LA; Williams KY; Gilbert DL
    J Am Pharm Assoc (Wash); 2000; 40(4):515-9. PubMed ID: 10932461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water.
    Meyer K; Santarossa M; Danziger LH; Wenzler E
    Hosp Pharm; 2017 Mar; 52(3):221-228. PubMed ID: 28439137
    [No Abstract]   [Full Text] [Related]  

  • 32. Stability of amrinone and digoxin, procainamide hydrochloride, propranolol hydrochloride, sodium bicarbonate, potassium chloride, or verapamil hydrochloride in intravenous admixtures.
    Riley CM; Junkin P
    Am J Hosp Pharm; 1991 Jun; 48(6):1245-52. PubMed ID: 1650135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical Compatibility of Meropenem and Vaborbactam With Select Intravenous Drugs During Simulated Y-site Administration.
    Kidd JM; Avery LM; Asempa TE; Nicolau DP; Kuti JL
    Clin Ther; 2018 Feb; 40(2):261-269. PubMed ID: 29290374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection.
    Wu G; Powers D; Yeung S; Chen F
    Int J Pharm Compd; 2018; 22(1):76-85. PubMed ID: 29385388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion.
    Kambia NK; Luyckx M; Dine T; Dupin-Spriet T; Gressier B; Brunet C
    J Clin Pharm Ther; 2009 Feb; 34(1):25-31. PubMed ID: 19125900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physical compatibility of remimazolam with opioid analgesics, sedatives, and muscle relaxants during simulated Y-site administration.
    Kondo M; Yoshida N; Yoshida M; Tanaka C; Tagami T; Horikawa K; Sugaya K; Takase H
    Am J Health Syst Pharm; 2023 Jan; 80(1):e53-e58. PubMed ID: 36094564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
    Avery LM; Chen IH; Reyes S; Nicolau DP; Kuti JL
    Clin Ther; 2019 Oct; 41(10):2162-2170. PubMed ID: 31506218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compatibility of aminophylline and methylprednisolone sodium succinate intravenous admixtures.
    Johnson CE; Cohen IA; Craft DA; Lizer MH
    Am J Hosp Pharm; 1986 Jun; 43(6):1482-5. PubMed ID: 3524206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compatibility of aztreonam with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Health Syst Pharm; 1995 May; 52(10):1086-90. PubMed ID: 7656099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability and compatibility of methylprednisolone sodium succinate and cimetidine hydrochloride in 5% dextrose injection.
    Strom JG; Miller SW
    Am J Hosp Pharm; 1991 Jun; 48(6):1237-41. PubMed ID: 1858803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.